Pembrolizumab: Solution concentrate for I.V. infusion, 100 mg in 4 mL; Keytruda® Page last updated: 1 March 2019 Public Summary Document (PSD) November 2018 PBAC Meeting - (PDF 1.4 MB) Public Summary Document (PSD) November 2018 PBAC Meeting - (Word 102 KB)